The setback likely removes one competitor to an emerging spinal muscular atrophy medicine from Scholar Rock, but sets the ...

Winrevair treats pulmonary arterial hypertension, a condition that makes pumping blood through the lungs harder and ...

Reduced Weight Regain: CCT-217 shows promise in preventing weight regain commonly observed after discontinuing incretin ...

The approval of Attruby for transthyretin amyloidosis with cardiomyopathy begins a battle for control of a lucrative market ...

Evotec appears to have rebuffed Halozyme’s $2.1 billion acquisition attempt. Elsewhere, Argenx has another blockbuster target ...

A prolific medical research and author, Martin Makary criticized the FDA and CDC for their decision-making during the ...

The startup, Pep2Tango, is combining four methods of accelerating weight loss into one medicine in the hopes of developing a ...

The restructuring follows the company's receipt of a letter from the FDA citing "deficiencies" in its approval application ...

In buying Westlake-backed Kate Therapeutics, Novartis gets a handful of preclinical gene therapies targeting diseases like ...

Built around research by Stanford scientist Carolyn Bertozzi and MIT researcher Jessica Stark, Valora Therapeutics is ...

Howard Chang will take over as chief scientific officer and senior VP of research as the biotech searches for more ways to ...

Venture capital firms incubate, grow and finance dozens of drug companies each year. Follow the money they channel into the ...